Metastatic prostate cancer cases skyrocket

The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The report considers whether a recent trend of fewer men being screened ...


Agreement high for prognostic cancer screening tools

(HealthDay)—For cancer screening in Medicare beneficiaries, there is substantial agreement for different prognostic tools for short- and long-term survival, according to a study published online April 30 in the Journal ...


Lower 25-OH D tied to adverse pathology in full prostatectomy

(HealthDay)—For men with localized prostate cancer undergoing radical prostatectomy, serum 25-hydroxyvitamin D (25-OH D) insufficiency/deficiency is associated with increased odds of adverse pathology, according to a study ...

page 5 from 19